Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1988-06-03
1990-05-08
Swisher, Nancy A. B.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424437, A61M 3100
Patent
active
049236997
ABSTRACT:
An ophthalmic treatment system is provided which includes three-dimensional particles of bioerodible material suspended in a liquid carrier or ointment carrier having a pH acceptable to the eye. The particles are at least 0.5 mm in greatest dimension and are not greater than 0.4 mm to 0.7 mm in smallest dimension when disposed in the ocular environment. The treatment system provides reliable, prolonged continuous treatment without irritating the eye.
REFERENCES:
patent: 3826258 (1974-07-01), Abraham
patent: 3845201 (1974-10-01), Haddad et al.
patent: 3914402 (1975-10-01), Shell
patent: 3968201 (1976-07-01), Ryde
patent: 4001388 (1977-01-01), Shell
patent: 4115544 (1978-09-01), Shell
patent: 4164559 (1979-08-01), Miyata et al.
patent: 4179497 (1979-12-01), Cohen et al.
"Collagen As A Biomaterial", Stenzel et al., pp. 233-253, 1974.
"Collagen As A Vehicle for Drug Delivery", Rubin et al., pp. 309-312, Aug.-Sep. 1973.
"Principles of Polymer Chemistry", Flory, pp. 49-68.
"Flow of Gases through Polyethylene", Michaels et al., Journal of Polymer Science, vol. L, pp. 413-439, (1961).
Contact Lens Practice, Robert B. Mandell (Charles C. Thomas, 1965), pp. 159-165.
"Cyanamide Research Develops World's First Synthetic Absorbable Suture", Chemistry and Industry, 7/11/70; p. 905.
General Opthalomogy, Vaughn et al, Eds., 11th Edition; Ch. 7, "Tears" Khalid F. Tabbara M.D., pp. 77-72.
LandOfFree
Eye treatment suspension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eye treatment suspension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eye treatment suspension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2348187